2024-09-21 - Analysis Report
## Amgen Inc. (AMGN) Stock Analysis Report

**Company Overview:** Amgen Inc. is a biotechnology company specializing in the development, manufacturing, and marketing of human therapeutics.

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return (AMGN):** 88.32%
* **Cumulative Return (VOO):** 133.16%
* **Performance Gap:** -44.84%
* **Relative Performance:** 40.97% (based on historical data)

Amgen has underperformed the S&P 500 (VOO) by 44.84%. This puts its relative performance at the 40.97th percentile compared to its historical performance against the S&P 500. 

**2. Recent Price Movement:**

* **Closing Price:** 336.05
* **5-Day Moving Average:** 333.74
* **20-Day Moving Average:** 329.55
* **60-Day Moving Average:** 326.54

The stock price is currently above all three moving averages, indicating a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 56.58 - The RSI suggests the stock is neither overbought nor oversold, and it could potentially move further upwards.
* **PPO:** 0.19 - The PPO is positive, suggesting an upward momentum in the price.
* **Delta_Previous_Relative_Divergence:** -0.36 -  A negative value suggests a potential short-term downward trend.
* **Expected Return:** 9.21% - This represents the maximum expected return over the next 5-10 years based on current investment levels. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-07 | 1.39 | 8.39 B$ |
| 2024-05-03 | -0.21 | 7.45 B$ |
| 2023-10-31 | 3.23 | 6.90 B$ |
| 2023-08-04 | 2.58 | 6.99 B$ |
| 2024-08-07 | 2.58 | 6.99 B$ |

The most recent earnings report (2024-08-07) showed EPS of 1.39, exceeding analysts' expectations. Revenue also surpassed expectations at 8.39 billion dollars. This positive earnings report suggests a strong performance for Amgen, potentially driving further upward price movement.

**5. Overall Analysis:**

While Amgen has underperformed the S&P 500 in the long term, recent price movement and technical indicators suggest a potential upward trend. The strong latest earnings report further supports this bullish outlook. However, the negative Delta_Previous_Relative_Divergence signals a potential short-term correction.

**Overall, AMGN shows potential for growth, but investors should monitor the short-term price trends closely.**
